HRT Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48.8M | Sell |
53,051
-6,838
| -11% | -$6.93M | 0.12% | 131 |
|
|
2025
Q4 | $64.4M | Buy |
+59,889
| New | +$57.3M | 0.2% | 65 |
|
|
2025
Q3 | – | Sell |
-27,387
| Closed | -$20.4M | – | 3311 |
|
|
2025
Q2 | $21.3M | Buy |
+27,387
| New | +$21.3M | 0.09% | 141 |
|
|
2025
Q1 | – | Sell |
-8,518
| Closed | -$7.09M | – | 2996 |
|
|
2024
Q4 | $6.58M | Sell |
8,518
-201,491
| -96% | -$167M | 0.03% | 324 |
|
|
2024
Q3 | $186M | Buy |
210,009
+208,211
| +11,580% | +$187M | 0.92% | 10 |
|
|
2024
Q2 | $1.63M | Sell |
1,798
-14,031
| -89% | -$11.2M | 0.01% | 811 |
|
|
2024
Q1 | $12.3M | Sell |
15,829
-9,846
| -38% | -$7.01M | 0.08% | 125 |
|
|
2023
Q4 | $15M | Buy |
25,675
+12,487
| +95% | +$7.29M | 0.11% | 106 |
|
|
2023
Q3 | $7.08M | Buy |
13,188
+11,526
| +694% | +$5.94M | 0.07% | 188 |
|
|
2023
Q2 | $779K | Sell |
1,662
-324,175
| -99% | -$136M | 0.01% | 1103 |
|
|
2023
Q1 | $112M | Buy |
325,837
+320,334
| +5,821% | +$108M | 1.37% | 7 |
|
|
2022
Q4 | $2.01M | Buy |
+5,503
| New | +$1.95M | 0.03% | 594 |
|
|
2022
Q3 | – | Sell |
-52,549
| Closed | -$16.6M | – | 3201 |
|
|
2022
Q2 | $17M | Buy |
+52,549
| New | +$15.8M | 0.19% | 77 |
|
|
2021
Q4 | – | Sell |
-25,229
| Closed | -$6.4M | – | 3675 |
|
|
2021
Q3 | $5.83M | Sell |
25,229
-31,248
| -55% | -$7.71M | 0.04% | 280 |
|
|
2021
Q2 | $13M | Buy |
56,477
+42,832
| +314% | +$8.6M | 0.12% | 151 |
|
|
2021
Q1 | $2.55M | Buy |
+13,645
| New | +$2.67M | 0.03% | 496 |
|
|
2020
Q4 | – | Sell |
-169,352
| Closed | -$25.1M | – | 2184 |
|
|
2020
Q3 | $25.1M | Buy |
+169,352
| New | +$26.2M | 0.73% | 23 |
|
|
2019
Q4 | – | Sell |
-3,254
| Closed | -$363K | – | 1426 |
|
|
2019
Q3 | $363K | Buy |
3,254
+961
| +42% | +$107K | 0.02% | 830 |
|
|
2019
Q2 | $254K | Buy |
+2,293
| New | +$270K | 0.02% | 581 |
|
|
2019
Q1 | – | Sell |
-28,290
| Closed | -$3.27M | – | 669 |
|
|
2018
Q4 | $3.27M | Buy |
+28,290
| New | +$3.16M | 0.47% | 43 |
|
|
2018
Q2 | – | Sell |
-15,748
| Closed | -$1.22M | – | 330 |
|
|
2018
Q1 | $1.22M | Buy |
15,748
+12,748
| +425% | +$1.03M | 0.58% | 37 |
|
|
2017
Q4 | $253K | Buy |
+3,000
| New | +$255K | 0.26% | 66 |
|
Other funds holding LLY
VCM
VPM
HRT Financial's LLY Position: Q1 2026 in Review
HRT Financial reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $6.93M and leaving 53,051 shares worth $48.8M. The position accounts for 0.12% of the portfolio, ranked #131.
HRT Financial first reported a position in LLY in Q4 2017 and has held it in 22 quarters since. The position peaked at $186M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- HRT Financial held 53,051 shares of Eli Lilly worth $48.8M as of Q1 2026.
- HRT Financial sold 6,838 Eli Lilly shares in Q1 2026, an estimated $6.93M.
- Eli Lilly made up 0.12% of HRT Financial's portfolio in Q1 2026, its #131 holding.
- HRT Financial first reported a position in Eli Lilly in Q4 2017 and has held it in 22 quarters since.
- HRT Financial's Eli Lilly position peaked at $186M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.